Aster DM Healthcare has received overwhelming support from shareholders and creditors for its proposed merger with Quality Care India Limited (QCIL), marking a key step toward creating one of India’s largest hospital networks. The company announced that 96.68% of shareholders voted in favour of the Scheme of Amalgamation, along with strong support from minority shareholders and creditors.
The transaction had earlier secured approvals from the Competition Commission of India (CCI) and stock exchanges. The merger is expected to be completed in the next quarter, subject to remaining statutory and regulatory approvals, including clearance from the National Company Law Tribunal (NCLT).
Following the merger, the combined entity — Aster DM Quality Care Ltd — will emerge as one of India’s top three hospital chains, with operations across nine states and 28 cities. The integrated platform will operate 39 hospitals with over 10,625 beds and a workforce of more than 36,000 employees and clinicians serving millions of patients annually.
Dr. Azad Moopen, Founder Chairman of Aster DM Healthcare, said the strong shareholder backing demonstrates confidence in the strategic value of the merger.
“The strong support from our shareholders reflects their confidence in the strategic rationale of this merger and the long-term value it will deliver. By bringing together Aster DM Healthcare and Quality Care India, we are building a scaled, future-ready healthcare platform capable of delivering high-quality care to millions of patients,” he said.
The combined entity also plans significant expansion, targeting a total capacity of over 14,710 beds in the coming years with planned additions of more than 4,080 beds. Aster alone will add around 2,368 beds through new hospitals and expansions across key markets such as Bengaluru, Kerala and Hyderabad, supported by a capital investment of approximately ₹2,300 crore.
